Free Trial

Barclays PLC Buys 66,263 Shares of Exponent, Inc. (NASDAQ:EXPO)

Exponent logo with Business Services background

Barclays PLC grew its position in Exponent, Inc. (NASDAQ:EXPO - Free Report) by 219.0% during the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 96,526 shares of the business services provider's stock after purchasing an additional 66,263 shares during the period. Barclays PLC owned approximately 0.19% of Exponent worth $11,127,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds also recently modified their holdings of EXPO. Quarry LP acquired a new stake in shares of Exponent in the 2nd quarter valued at approximately $25,000. Whittier Trust Co. of Nevada Inc. lifted its stake in Exponent by 166.5% in the second quarter. Whittier Trust Co. of Nevada Inc. now owns 517 shares of the business services provider's stock valued at $49,000 after acquiring an additional 323 shares during the last quarter. USA Financial Formulas acquired a new stake in Exponent in the third quarter valued at $60,000. GAMMA Investing LLC grew its position in shares of Exponent by 64.6% in the 3rd quarter. GAMMA Investing LLC now owns 624 shares of the business services provider's stock valued at $72,000 after acquiring an additional 245 shares during the period. Finally, Benjamin F. Edwards & Company Inc. increased its stake in shares of Exponent by 70.5% during the 2nd quarter. Benjamin F. Edwards & Company Inc. now owns 873 shares of the business services provider's stock worth $83,000 after purchasing an additional 361 shares during the last quarter. 92.37% of the stock is owned by institutional investors and hedge funds.

Exponent Stock Performance

NASDAQ:EXPO traded up $0.72 during mid-day trading on Tuesday, hitting $93.78. The stock had a trading volume of 289,195 shares, compared to its average volume of 242,603. Exponent, Inc. has a twelve month low of $68.70 and a twelve month high of $115.75. The stock has a market cap of $4.76 billion, a price-to-earnings ratio of 45.30 and a beta of 0.70. The company's 50 day simple moving average is $101.10 and its 200 day simple moving average is $102.37.

Exponent Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Friday, December 20th. Stockholders of record on Friday, December 6th will be paid a dividend of $0.28 per share. The ex-dividend date of this dividend is Friday, December 6th. This represents a $1.12 annualized dividend and a dividend yield of 1.19%. Exponent's dividend payout ratio is currently 54.11%.

Insider Buying and Selling

In related news, Director Carol Lindstrom sold 1,039 shares of Exponent stock in a transaction that occurred on Monday, November 4th. The stock was sold at an average price of $96.32, for a total transaction of $100,076.48. Following the completion of the sale, the director now directly owns 5,871 shares of the company's stock, valued at approximately $565,494.72. This trade represents a 15.04 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, Director Paul R. Johnston sold 14,000 shares of the company's stock in a transaction on Wednesday, November 6th. The shares were sold at an average price of $104.60, for a total value of $1,464,400.00. Following the completion of the transaction, the director now directly owns 80,742 shares in the company, valued at approximately $8,445,613.20. This represents a 14.78 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last three months, insiders have sold 30,339 shares of company stock valued at $3,103,065. 2.10% of the stock is owned by insiders.

Exponent Profile

(Free Report)

Exponent, Inc, together with its subsidiaries, operates as a science and engineering consulting company in the United States and internationally. The company operates in two segments, Engineering and Other Scientific, and Environmental and Health. The Engineering and Other Scientific segment provides services in the areas of biomechanics, biomedical engineering and sciences, buildings and structures, civil engineering, construction consulting, data sciences, electrical engineering and computer science, human factors, materials and corrosion engineering, mechanical engineering, polymer science and materials chemistry, thermal sciences, and vehicle engineering.

Read More

Institutional Ownership by Quarter for Exponent (NASDAQ:EXPO)

→ Did You See Trump’s Bombshell Exec. Order 001? (From Banyan Hill Publishing) (Ad)

Should you invest $1,000 in Exponent right now?

Before you consider Exponent, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Exponent wasn't on the list.

While Exponent currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

20 High-Yield Dividend Stocks that Could Ruin Your Retirement Cover

Almost everyone loves strong dividend-paying stocks, but high yields can signal danger. Discover 20 high-yield dividend stocks paying an unsustainably large percentage of their earnings. Enter your email to get this report and avoid a high-yield dividend trap.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

From Landfills to Profits: Opal Fuels CEO Shares How the Company Turns Trash into Cash
The Real Reason Tesla Stock Is Soaring – and Why Tech Expert Says It Won’t Stop
Best ETFs for 2025: Growth, Stability, and AI-Driven Investing

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines